Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States.
Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Australia; University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Australia; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Australia.
De-partment of Epidemiology and Population Health, Albert Einstein College of Medicine, NY, Bronx, United States.
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, MO, St Louis, United States; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, MO, St. Louis, United States; Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, MO, St. Louis, United States.
Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, MA, Boston, United States; Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, MA, Boston, United States; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, MA, Boston, United States; Broad Institute of Harvard and MIT, MA, Cambridge, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States.
Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, MA, Boston, United States; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, MA, Boston, United States.
Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, MN, Rochester, United States.
Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Australia; University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Australia.
De-partment of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States; Broad Institute of MIT and Harvard, MA, Cambridge, United States; Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, MA, Boston, United States.
Department of Medical Oncology and Therapeutics Research, Center for Precision Medicine, City of Hope National Medical Center, CA, Duarte, United States.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Epidemiology, University of Washington School of Public Health, WA, Seattle, United States.
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Biostatistics, University of Washington, WA, Seattle, United States.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Barcelona, Spain; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDI-BELL), L’Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L’Hospitalet de Llobregat, Barcelona, Spain.
Department of Population Science, American Cancer Society, GA, Atlanta, United States.
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, MA, Boston, United States.
Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Barcelona, Spain; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDI-BELL), L’Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L’Hospitalet de Llobregat, Barcelona, Spain.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States; Broad Institute of MIT and Harvard, MA, Cambridge, United States; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, MA, Boston, United States; Tokyo Medical and Dental University (Institute of Science Tokyo), Tokyo, Japan.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Genomic Medicine Institute, Cleveland Clinic, OH, Cleveland, United States; Population and Cancer Prevention Program, Case Comprehensive Cancer Center, OH, Cleveland, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States.
Department of Cancer Biology and Genetics, Comprehensive Cancer Center, Ohio State University, OH, Columbus, United States; Department of Internal Medicine, Comprehensive Cancer Center, Ohio State University, OH, Columbus, United States.
Ontario Institute for Cancer Research, Toronto, Canada.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States.
Department of Population Science, American Cancer Society, GA, Atlanta, United States.
Ontario Institute for Cancer Research, Toronto, Canada.
Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Epidemiology, University of Washington School of Public Health, WA, Seattle, United States.
Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Epidemiology, University of Washington School of Public Health, WA, Seattle, United States.
Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
American Association For Cancer Research (AACR), 2025. Vol. 34, no 4, p. 568-577